title: The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.
authors.affiliation: Inserm, U920, Talence, F-33400, France.
authors.forename: S
authors.initials: S
authors.lastname: Dedieu
authors.forename: X
authors.initials: X
authors.lastname: Canron
authors.forename: H R
authors.initials: HR
authors.lastname: Rezvani
authors.forename: M
authors.initials: M
authors.lastname: Bouchecareilh
authors.forename: F
authors.initials: F
authors.lastname: Mazurier
authors.forename: R
authors.initials: R
authors.lastname: Sinisi
authors.forename: M
authors.initials: M
authors.lastname: Zanda
authors.forename: M
authors.initials: M
authors.lastname: Moenner
authors.forename: A
authors.initials: A
authors.lastname: Bikfalvi
authors.forename: S
authors.initials: S
authors.lastname: North